Form 4 for IDXX Idexx Laboratories
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0000874716-25-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-18 | 2025-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | A - Grant | $0.00 | +704 | 5,779 | +14% | $0 |
| D | 2025-02-18 | 2025-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | F - Tax | $444.53 | -219 | 6,127 | -3% | -$97.4K |
| DM | 2025-02-18 | 2025-02-13 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | A - Grant | $0.00 | +5,781 | 4,504 | New | $0 |
| DM | 2025-02-18 | 2025-02-14 | IDXX | Underberg Sharon E. | EVP, GC, Corp. Sec | M - OptEx | $0.00 | -704 | 652 | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | A | A | 218 | $0.00 | 6,345.94 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | A | A | 176 | $0.00 | 6,127.94 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-14 | A | A | 173 | $0.00 | 5,951.94 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-14 | A | A | 137 | $0.00 | 5,778.94 | D | — | — | (F1) Includes a total of 47 shares purchased under the Issuer Employee Stock Purchase Plan on March 29, 2024, June 28, 2024, September 30, 2024 and December 31, 2024. |
| 5 | Common | Common Stock | 2025-02-14 | F | D | 219 | $444.53 | 6,126.94 | D | — | — | |
| 6 | Derivative | Incentive Stock Option (right-to-buy) | 2025-02-13 | A | A | 217 | $0.00 | 217 | D | $459.76 · — to 2035-02-12 | 217 Common Stock | (F3) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029. |
| 7 | Derivative | Restricted Stock Unit | 2025-02-13 | A | A | 1,060 | $0.00 | 1,060 | D | — · — to — | 1,060 Common Stock | (F4) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026. |
| 8 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 137 | $0.00 | 0 | D | — · — to — | 137 Common Stock | (F5) Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022. |
| 9 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 173 | $0.00 | 173 | D | — · — to — | 173 Common Stock | (F6) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023. |
| 10 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 176 | $0.00 | 352 | D | — · — to — | 176 Common Stock | (F7) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024. |
| 11 | Derivative | Restricted Stock Unit | 2025-02-14 | M | D | 218 | $0.00 | 652 | D | — · — to — | 218 Common Stock | (F8) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025. |
| 12 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2025-02-13 | A | A | 4,504 | $0.00 | 4,504 | D | $459.76 · — to 2035-02-12 | 4,504 Common Stock | (F2) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026. |